CS Paper Radar

Can decision models extract clinical data from cancer pathology reports? An evaluation of accuracy, calibration, and failure modes

Indranil Mallick, Paromita Roy

cs.CL cs.AIcs.LG ·submitted 2026-11-15 16:57 UTC · v1

Abstract

Decision models are a new class of language model that, instead of generating text, choose one option per question from a fixed list and return a probability for every option. They have not yet been evaluated on clinical text. We evaluated two open-weights decision models, Nimble 9B and Tev1 4B, for extracting 25 fields from 1,113 oral cavity cancer pathology reports from a single centre, against a prospectively maintained clinical database. We compared them with two generative models: Qwen3.5 9B, run locally, and GLM-5.3-flash, run through a cloud API. Tev1 reached a mean field accuracy of 0.917 (95% CI 0.913 to 0.920), the same as Qwen3.5 9B (0.918; p = 0.26), and was four times faster (15 s against 61 s per report). Nimble reached 0.862 and GLM-5.3-flash 0.986. Both decision models matched GLM-5.3-flash on simple dichotomous categories. They were weak on measurements binned into categories, on fields whose correct answer was not reported, and on some complex decisions (e.g. involved margins). We found that the main cause of the inferior performance of Nimble's came from asking 25 questions in one request: with two questions per request, its accuracy improved. Pooled over fields, the returned probabilities were well calibrated (expected calibration error 0.022 and 0.026), but they did not flag systematic errors within single fields. A simulated strategy of sending answers with a probability below 0.94 to GLM-5.3-flash raised Tev1's accuracy to 0.982, with 38% of answers escalated. Decision models can extract explicitly stated findings from pathology reports quickly on local hardware and return useful probabilities. They should be validated in the configuration in which they will be used, restricted to the fields in which they are reliable, and combined with other methods for numeric values.

Comment
22 pages, 7 figures

Closest papers

Nearest neighbours by meaning across the whole index.

Benchmarking decision models against generative large language models on medical multiple-choice questions

cs.CL cs.AI ·2026-10-28 ·Oscar Freyer, Daniel Glauert, Moritz Hofmann, Max Ostermann, Stephen Gilbert +1 more
similarity 0.68
Abstract

Medical workflows often require selecting among predefined options. We compared 13 decision models with 15 generative large language model configurations, including different reasoning settings, using 1,273 four-option MedQA questions under text-only conditions. Accuracy ranged from 67.71% to 89.08% for decision models and from 78.32% to 96.86% for generative configurations. Among the tested configurations, Mercury Decide had the lowest mean final-attempt cost (USD 0.0069 per 1,000 questions), while Clef Omni had the shortest median request duration (0.291 seconds). Decision-model probabilities distinguished correct from incorrect answers, but error rates among answers assigned probabilities of at least 0.90 ranged from 1.71% to 12.77%. Answer agreement across three runs ranged from 92.30% to 100%, while probability repeatability varied. Decision models offered resource advantages alongside lower peak accuracy; selecting models for medical workflows requires considering probability quality and repeatability together with accuracy and the resources needed to detect and correct errors.

0.22

A general-purpose System One decision model for clinical records

cs.AI ·2026-10-19 ·Andrew Zhang, Trinh T. L. Vuong, Sophia J. Wagner, Dongmin Bang, Tong Ding +12 more
similarity 0.65
Abstract

Clinical care, health-system operations and biomedical discovery depend on extracting reliable answers from patient records, yet applying diverse clinical questions across entire populations remains computationally expensive. Here we present Clinical System One (CS1), a 4-billion-parameter decision model for fast, typed judgments from clinical records, along with two agentic harnesses in which CS1 works together with a generalist language model. CS1-4B is trained on 12.4 million questions and answers from 3.6 million patients across a multi-hospital health system, combining structured-data keys, observed outcomes and language-model supervision across clinical notes, diagnostic reports and patient timelines. It answers multiple typed questions in a single forward pass without task-specific retraining, and each answer carries a probability that can route uncertain cases to human review. On 963,408 held-out patients, CS1-4B outperformed open decision models up to 27 billion parameters on 13 of 14 tasks scored independently of its training teacher. Across 21 external data sets, its aggregate performance approached that of the strongest tested 27-billion-parameter model, with 6.4-fold faster inference in a matched workload. Integrating CS1-4B with a language model agent produced cited answers over complete multi-year patient histories and screened a patient population against the eligibility criteria of 17 registered clinical trials, placing four times as many judged-eligible patients among its top 20 candidates as keyword search while using 690-fold fewer language-model tokens than a language model reading every record. These findings support a division of labour in clinical AI, with small decision models performing repeated record reading and generative models formulating questions and synthesizing evidence.

0.42

How Reliable Are System-One Decisions in Medicine? A Comparative Study of Jev, Jev-like Models, and LLMs

cs.CL ·2026-10-13 ·Yanrui Du, Danyang Zhao, Sendong Zhao, Wenhao Li, Yibo Gao +4 more
highly cited similarity 0.65
Abstract

Jev has attracted considerable attention for its rapid, generalizable decision-making, yet its medical reliability remains underexplored. To address this gap, our study compares various types of system-one decision models across 15 medical datasets comprising 8,742 instances under a unified protocol. Beyond accuracy, we assess decision stability and the ability to recognize unreliable decisions. Our results show that Jev rivals leading models on primarily text-driven tasks but is less effective on numerically driven tasks, revealing a distinct capability boundary. Under question-format variations, Jev maintains strong decision consistency and small accuracy fluctuations. StartLux-27B exhibits comparable consistency, while D3-27B achieves higher overall accuracy and a lower mean decision reversal rate. But these strengths do not extend to reliable abstention awareness: most evaluated models show limitations in both recognizing missing correct answers and using optional abstention. Moreover, we find that Jev's probability-based answer selection can be improved by changing how decisions are scored: normalizing option-wise binary scores yields higher retained accuracy than choice scoring. Taken together, our findings provide early guidance for improving and applying decision models in medicine.

0.45

TrialJev: Open-Weight Single Pass Eligibility Scoring for Patient Trial Screening

cs.LG ·2026-11-06 ·Omar Ibrahim, Grant Hamblin, Benjamin Haibe-Kains
code/data similarity 0.64
Abstract · 38 pages. Code: https://github.com/oibrahi1/TrialJev. Models: https://huggingface.co/omareng/TrialJev

Clinical trial screening requires assessing large numbers of patient-trial pairs to prioritize candidates for detailed eligibility review, often under restrictions on sharing patient records. We introduce TrialJev, an open-weight eligibility scorer that uses LoRA-adapted Qwen models and a pointer head to score natural-language answer options in a single forward pass, without autoregressive decoding. Trained on TREC Clinical Trials 2021 and evaluated on 6,975 eligible-or-excluded pairs from 50 unseen TREC 2022 synthetic patients, TrialJev achieves 80.97% (Qwen3.5-27B) and 81.84% (Qwen3.8-27B) accuracy, compared with 79.87% and 79.93% for LLMs fine-tuned on the same data to generate verdicts. In matched batch-1 measurements, verdict generation takes 2.45-2.70 times as long as the one-pass inference of TrialJev at 9B-27B. Under a common development-fitted decision correction, the two 27B TrialJev models reach 80.99% and 81.88% accuracy, compared with 81.28% for the proprietary hosted Jev API; paired confidence intervals include zero. TrialJev runs locally on a single GPU, requiring approximately 178 ms per pair at 27B, without transmitting patient text to an external model API. An A/B-logit ablation shows that avoiding decoding, rather than the pointer head alone, accounts for the measured efficiency advantage. TrialJev is intended for first-pass prioritization of candidate trials, complementing rather than replacing explanatory models and clinical review. Evaluation is limited to synthetic patients and implementation-specific timing, and clinical use has not been validated. Adapters, pointer heads, and model cards are released on Hugging Face.

0.22

Is a 9B Decision Foundation Model Needed for Symptom-to-Disease Classification? Fine-Tuning Clef-Flash Against TF-IDF Baselines

cs.CL cs.AI ·2026-10-10 ·S. M. Mahbub Uddin Ahmed
benchmarkcode/data similarity 0.64
Abstract · v2: Corrected reported results against saved experiment outputs; added same-split TF-IDF baselines (which outperform the fine-tuned model); …

Disease classification from patient-reported symptom descriptions is usually approached with lightweight discriminative models or with autoregressive large language models (LLMs), which understand language broadly but generate text token by token and require output parsing. We study decision foundation models, which score a closed set of candidate labels in a single forward pass without generating text. We adapt Clef-Flash, a 9-billion parameter decision model built on a Qwen3.5 backbone, to the 24-class Symptom2Disease benchmark using 4-bit quantized low-rank adaptation (QLoRA) on a stratified split of 960 training and 240 test cases. The fine-tuned model reaches 95.42% accuracy (95% CI 91.98-97.42%) and a macro F1 of 0.9551, up from 65.00% for the unadapted weights (62.92% through the remote API). However, TF-IDF linear SVM and logistic regression baselines trained on the same split reach 98.75% (95% CI 96.39-99.57%) with sub-millisecond CPU inference, so on this benchmark the fine-tuned model offers no accuracy advantage over a well-tuned linear classifier. A Leave-One-Symptom-Out clause-ablation analysis of four illustrative narratives shows predictions depending on distinguishing clauses: in a psoriasis example, removing the clause describing silvery scales lowers the predicted probability from above 99.99% to 0.12% and shifts the prediction to impetigo, while removing other clauses changes it by less than 0.001 percentage points. Decision architectures deliver structured, single-pass predictions from large language backbones, but short, lexically distinctive benchmarks such as Symptom2Disease cannot show an advantage over simple baselines; validation on longer, real clinical text and clinician review are needed.

0.29

OmniMed-Jev: Calibrating LVLM Confidence for Trustworthy Medical Multimodal Decisions via System One

cs.LG ·2026-09-30 ·Luyao Tang, Cheng Chen
code/data similarity 0.64
Abstract · We introduce OmniMed-Jev, a decision-native interface based on Jev that outputs Choice, Noul or Score decisions with calibrated probabilitie…

Medical models are judged not only on correctness, but on whether reported confidence matches actual accuracy. Generalist multimodal medical models have expanded what a single model can perceive, yet they still express bounded decisions such as diagnoses, findings or cell counts as generated text, so the reported probability reflects the next token rather than the decision itself. Motivated by decision-native interfaces such as Jev, we introduce OmniMed-Jev, which represents each medical decision as a Choice, Noul or Score decision over a runtime-supplied candidate set and returns a full distribution over that set: mutually exclusive classes, binary presence of a finding, or a bounded ordered value. The design is omni in three respects: it accepts diverse imaging modalities, covers different prediction tasks, and expresses them through one candidate-conditioned probability model, so heterogeneous outputs become comparable probabilities rather than task-specific strings. In an interface-controlled comparison against a generative baseline trained on the same backbone, data and schedule, OmniMed-Jev's reported probabilities track observed correctness far more closely, reducing calibration error by up to an order of magnitude and reliability error by up to two, while point-prediction performance remains comparable; counting is the one family where the generative baseline stays ahead. Making the decision distribution the model's output is not a format change but what turns reported numbers into probabilities that mean what they say. These results support explicit decision modeling as a way to make reported confidence meaningful within the evaluated tasks, and they are not evidence of clinical readiness: the comparison cannot separate the interface from associated training differences, which we state alongside the results. Code is available at github.com/lytang63/OmniMed-Jev.

0.56

Native Probability Outputs for Clinical Triage: An Evaluation of Calibration and Decision Accuracy

cs.LG stat.AP ·2026-10-17 ·Liang You, Zhiyin Zhou, Dawei Tang, Chuchu Wu, Jingzhuo Hu
similarity 0.63
Abstract

Patient-facing triage requires an appropriate care recommendation and recognition of when information is insufficient. We evaluate whether Jev, a decision model that returns probabilities over predefined actions, supports both judgments. Using CARE-Bench, we compare Jev with four general-purpose language models and three input-independent baselines across 925 decision points from 439 public cases. On the public test subset, Jev ranks fourth of five models by macro-F1 (0.461) but has the lowest observed multiclass Brier score (0.610), an 18.7\% improvement over uniform prediction (case-bootstrap 95\% interval, 4.9--31.1\%). Noul has lower binary Brier than Choice (0.215 versus 0.276). A evaluation of 453 HealthBench conversations again gives Jev the lowest observed Brier score (0.299), but measures a distinct emergency-referral judgment. Jev combines lower probability error with missed clarification needs in the four-action task. Asking about information sufficiency separately increases recall but also produces frequent unnecessary clarification assignments.

0.10

MedJev: Evaluating Zero-Shot System-One Decision Making in Medicine

cs.CL cs.AIcs.LG ·2026-10-26 ·Simon A. Lee, Jiahang Sha, Moonseong Jeong, Yunbei Pan, Jeffrey N. Chiang
similarity 0.63
Abstract

System One decision models such as Jev answer structured questions in a single forward pass without generating text, offering fast and computationally efficient clinical decision support. We evaluate MedJev, an open System One model that runs locally on a laptop, across ten medical benchmarks spanning medical knowledge, diagnosis, and patient level prediction using MIMIC IV and MIMIC IV ED. We compare MedJev against zero shot LLM baselines, published GPT results, and supervised models. MedJev achieves accuracies of 72.5 percent on MedQA, 75.4 percent on USMLE, and 80.1 percent on NEJM, approaching published GPT 4 performance while maintaining well calibrated confidence estimates (ECE 0.028 to 0.063). On patient level tasks, MedJev achieves an AUROC of 0.926 for In Hospital Mortality, exceeding XGBoost (0.902), but underperforms supervised models on operational outcomes such as ED Triage Admission (0.745 vs. 0.809). Patient level predictions also exhibit substantial miscalibration (In Hospital Mortality ECE 0.286). We introduce a lightweight, two parameter recalibration method that adapts predictions to local patient populations using 50 to 200 labeled examples, reducing ECE to 0.007. Our findings establish open System One models as a promising zero shot baseline for medical AI, combining competitive predictive performance with low computational cost and efficient local calibration. We release our code and evaluation harness to support future research.

0.24